Annals of internal medicine

• Latest
• Best
• Search…

• Ann. Intern. Med. · Sep 2020

  Comment

  In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year.

  Gimbel M, Qaderdan K, Willemsen L, et al. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet. 2020;395:1374-81. 32334703.

  explore more… or not…

• Ann. Intern. Med. · Sep 2020

  Comment

  In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding.

  Baldetti L, Melillo F, Moroni F, et al. Meta-analysis comparing P2Y12 inhibitors in acute coronary syndrome. Am J Cardiol. 2020;125;1815-22. 32305225.

  read more… or not…

• Ann. Intern. Med. · Sep 2020

  Comment

  5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19.

  Reynolds HR, Adhikari S, Pulgarin C, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382:2441-8. 32356628.

  explore further… or just mark as read…

• Ann. Intern. Med. · Sep 2020

  Bonds in Every Color.

  no abstract available

  read more… or not…

• Ann. Intern. Med. · Sep 2020

  Comment

  Addressing Patient Bias Against Health Care Workers: Time for Meaningful Change.

  no abstract available

  read on… mark as read…